Here at the Janssen Health Policy Centre
our mission is to raise awareness on issues impacting healthcare policy, build
consensus through dialogue, and shape recommendations for future policies

Report-04/05/2016
Financing the future: Choices and challenges in global health

In a new report, sponsored by Johnson & Johnson, the parent company of Janssen, The Economist Intelligence Unit looks at the value of health to an economy.

download
Report-04/05/2016
The Impact of Health on Development

A new study by Precision Health Economics, a research organisation, examines existing literature on the impact of health on development and assesses the economic and societal yield of Investments in Health Care. The study was funded by Johnson & Johnson, Janssen’s parent company.

download
Report-04/12/2015
The shifting landscape of healthcare in Asia-Pacific

This report, written by the Economist Intelligence Unit (EIU) and supported by Janssen, seeks to compare and contrast the challenges and opportunities arising from the disease burden in the region. It also aims to identify best practices that might be shared to improve the support offered to people with non-communicable disease and infectious disease across five countries.

download

The shifting landscape of healthcare in Asia-Pacific

A look at Australia, China, India, Japan, and South Korea

This report, written by the Economist Intelligence Unit (EIU) and supported by Janssen, seeks to compare and contrast the challenges and opportunities arising from the disease burden in the region. It also aims to identify best practices that might be shared to improve the support offered to people with non-communicable disease and infectious disease across five countries.

In contrast to Europe, the Asia-Pacific region is typified by diverse approaches to healthcare amongst countries with a range of different political and economic backgrounds— countries that are thought of as high income mix with others with significant growth potential and with those that have seen recent rapid growth. As a consequence countries in the region lie at varying stages along the epidemiological transition— the movement from infectious diseases being the primary healthcare burden on a country to non-communicable diseases

Financing the future

Choices and challenges in global health

In a new report, sponsored by Johnson & Johnson, the parent company of Janssen, The Economist Intelligence Unit looks at the value of health to an economy.

A population’s health plays a key role in economic progress, and in coming years healthcare will be a key area of focus for policymakers, payers, providers and the public alike. Financing the future: Choices and challenges in global health studies the role of healthcare against a backdrop of changing demographic patterns, rising healthcare costs and technological innovation. The briefing paper highlights several effective approaches particular countries have adopted in response to funding challenges, and also shines a light on companies that have implemented programs supporting their employees.
As a basis for the research, the Economist Intelligence Unit (EIU) conducted a global survey in May and June 2015 to explore the impact of health on society and businesses. The survey tapped the opinions of 300 executives and managers: 150 from the private sector and 150 working in government and non-governmental organisations (NGOs). Respondents were based in North America (90), Asia-Pacific (90, with 30 from China and 30 from India) and Europe (90), with the remaining 30 hailing from the rest of the world. To complement and further explore the survey data, the EIU conducted in-depth interviews with experts from across the world.

Download the report here.

Download the report

 

The Impact of Health on Development

A new study by Precision Health Economics, a research organisation, examines existing literature on the impact of health on development and assesses the economic and societal yield of Investments in Health Care. The study was funded by Johnson & Johnson, Janssen’s parent company.

A holistic understanding of the interdependence between health and wealth would allow to work toward a more comprehensive evaluation of the effects of health on economic and social development. Currently, many economists believe the return on investment in health care has a long-term benefit to society seen not only in future gains in health, but also in gross domestic product (GDP) growth as well as other indicators of welfare and economic growth. However, the measurement of these returns in policy evaluation is often limited to gains in health outcomes.

A review of the literature on this relationship shows a strong, positive association between health and wealth. In general, there are two types of empirical studies on the relationship between health and wealth: individual level and country level.

Download the report here.

Related News


The shifting landscape of healthcare in Asia-Pacific

This report, written by the Economist Intelligence Unit (EIU) and supported by Janssen, seeks to compare and contrast the challenges and opportunities arising from the disease burden in the region. It also aims to identify best practices that might be shared to improve the support offered to people with non-communicable disease and infectious disease across five countries.

04/12/2015 Find out more

Report archive